CC
ZURA icon

Commodore Capital’s Zura Bio ZURA Stock Holding History

Commodore Capital’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2M Hold
3,250,000
– – 1.14% 21
2026
Q1 		$19.3M Buy
+3,250,000
New +$19.6M 1.12% 26

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Commodore Capital's ZURA Position: Q2 2026 in Review

Commodore Capital held its Zura Bio (ZURA) position steady in Q2 2026 at 3,250,000 shares worth $19.2M. The position accounts for 1.14% of the portfolio, ranked #21.

Commodore Capital first reported a position in ZURA in Q1 2026 and has held it in 2 quarters since. The position peaked at $19.3M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Commodore Capital held 3,250,000 shares of Zura Bio worth $19.2M as of Q2 2026.
  • Commodore Capital left its Zura Bio share count unchanged in Q2 2026.
  • Zura Bio made up 1.14% of Commodore Capital's portfolio in Q2 2026, its #21 holding.
  • Commodore Capital first reported a position in Zura Bio in Q1 2026 and has held it in 2 quarters since.
  • Commodore Capital's Zura Bio position peaked at $19.3M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Commodore Capital's 13F filing for Q2 2026, filed 14 Aug 2026.